A tumefactive demyelinating lesion in a person with MS after five years of fingolimod. [electronic resource]
- Multiple sclerosis and related disorders May 2020
- 101978 p. digital
Publication Type: Case Reports; Journal Article
2211-0356
10.1016/j.msard.2020.101978 doi
Adult Brain--diagnostic imaging Fingolimod Hydrochloride--adverse effects Humans Immunosuppressive Agents--adverse effects Magnetic Resonance Imaging Male Multiple Sclerosis, Relapsing-Remitting--drug therapy